Pfizer boosts cancer drug roster with $14 billion Medivation deal | Reuters

Pfizer boosts cancer drug roster with $14 billion Medivation deal | Reuters

Reuters August 23, 2016, 02:45:06 IST

Advertisement
Pfizer boosts cancer drug roster with $14 billion Medivation deal
| Reuters

This story has not been edited by Firstpost staff and is generated by auto-feed.

Latest News

Find us on YouTube

Subscribe

Top Shows

Vantage First Sports Fast and Factual Between The Lines